You are here: All Products  > Akeso Starts Phase III Trial of Bispecific Immunotherapy for NSCLC

Akeso Starts Phase III Trial of Bispecific Immunotherapy for NSCLC

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products